Adenoviral Vectors for Gene Therapy 2002
DOI: 10.1016/b978-012199504-1/50023-7
|View full text |Cite
|
Sign up to set email alerts
|

Imaging Adenovirus-Mediated Gene Transfer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2014
2014

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 89 publications
0
1
0
Order By: Relevance
“…In particular, the use of adenoviral vectors for molecular imaging of cancer offers opportunities to non-invasively gain information regarding tumor location as well as disease-specific information with regards to metabolism, receptor expression or tumor vascularity. 25 Much of the development and clinical application of viral-based vector strategies, however, has been limited by their associated immunogenicity, pathogenicity, and natural tropism. The diagnostic adenovirus, Ad5/3-Id1-SEAP-Id1-mCherry, investigated in this work overcomes many of the challenges commonly associated with viral vectors since it is replication defective and engineered to demonstrate enhanced cancer-specific infectivity.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, the use of adenoviral vectors for molecular imaging of cancer offers opportunities to non-invasively gain information regarding tumor location as well as disease-specific information with regards to metabolism, receptor expression or tumor vascularity. 25 Much of the development and clinical application of viral-based vector strategies, however, has been limited by their associated immunogenicity, pathogenicity, and natural tropism. The diagnostic adenovirus, Ad5/3-Id1-SEAP-Id1-mCherry, investigated in this work overcomes many of the challenges commonly associated with viral vectors since it is replication defective and engineered to demonstrate enhanced cancer-specific infectivity.…”
Section: Discussionmentioning
confidence: 99%